![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/discgenics-announces-us-fda-approval-to-proceed-with-phase-iii-clinical-evaluation-of-allogeneic-injectable-disc-progenitor-cell-therapy-for-symptomatic-lumbar-degenerative-disc-disease-302198029.html
https://www.prnewswire.com/news-releases/discgenics-to-present-at-41st-annual-jp-morgan-healthcare-conference-301713390.html
https://www.prnewswire.com/news-releases/two-year-clinical-data-for-discgenicss-progenitor-cell-therapy-for-lumbar-disc-degeneration-to-be-presented-at-nass-2022-301646093.html
https://www.prnewswire.com/news-releases/discgenics-to-present-at-2022-cell--gene-meeting-on-the-mesa-301641614.html